Meghan Good

Meghan Good

Research Manager

After graduating from the University of Bristol with a BSc in Neuroscience, Meghan went on to complete her MRes at Imperial College London with Distinction where she developed her experience and interest in psychedelic research, brain imaging and statistical analysis.

Meghan is a member of the clinical team, assisting with the data analytics and imaging aspects of research and is also responsible for the non-clinical aspects of Small Pharma’s drug development programme.

Before joining Small Pharma in 2020, she worked in management consulting and clinical research in the NHS

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: